Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Azeliragon

Review the clinical trials studying azeliragon on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-4 of 4

Azeliragon to Decrease Cancer Therapy Related Cardiotoxicity and Cognitive Impairment in Patients with Stage I-III Breast Cancer
Status: Active
Location: 3 locations
Azeliragon With Craniospinal Irradiation for the Treatment of Leptomeningeal Metastasis from Solid Tumor Cancer or High-grade Gliomas
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Status: Active
Location: See ClinicalTrials.gov
Neoadjuvant Chemoradiotherapy with or without Azeliragon for the Treatment of Newly Diagnosed Glioblastoma
Status: Approved
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri